Halozyme Therapeutics shares owned by Livforsakringsaktiebolaget Skandia
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Livforsakringsaktiebolaget Skandia
from 13F filings
Historical chart of Livforsakringsaktiebolaget Skandia investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Livforsakringsaktiebolaget Skandia consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Livforsakringsaktiebolaget Skandia
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $7.7M | 105k | 73.32 |
| 2025-06-30 | $5.3M | 102k | 52.01 |
| 2025-03-31 | $3.7M | 57k | 63.74 |
| 2024-12-31 | $2.7M | 57k | 47.80 |
| 2024-09-30 | $3.3M | 57k | 57.21 |
| 2024-06-30 | $2.4M | 46k | 52.35 |
| 2024-03-31 | $215k | 5.3k | 40.63 |
| 2023-12-31 | $196k | 5.3k | 36.96 |
More positions owned by Livforsakringsaktiebolaget Skandia
View all positions for Livforsakringsaktiebolaget Skandia